Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Examining the uptake of predictive BRCA testing in the UK; findings and implications

16 Dec 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Ethics in Clinical Research
Share to Health Systems, Economic Evaluations, Quality of Life

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33328582
DOI: 10.1038/s41431-020-00783-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Examining the uptake of predictive BRCA testing in the UK; findings and implicationsPMID 33328582Read ↗

Uptake of BRCA1/BRCA2 predictive genetic testing in an Irish population is low: a missed opportunity.Semantic proximity Read ↗

Using lessons learned from BRCA testing and marketing: what lies ahead for whole genome scanning services.Semantic proximity Read ↗

Update: variable implementation of the 2018 UKCGG/UKGTN guidelines for breast cancer gene panel tests offered by UK genetics services.Semantic proximity Read ↗

Pros and cons of screening for BRCA mutations.Semantic proximity Read ↗

When, how and why BRCA1 and BRCA2 genetic testing is offered to patients who do not meet standard criteriaSemantic proximity Read ↗

Genetic testing for familial/hereditary breast cancer—comparison of guidelines and recommendations from the UK, France, the Netherlands and GermanySemantic proximity Read ↗

Increasing the Uptake of Cancer Risk Management Strategies for Women With BRCA1/2 Sequence Variations.Semantic proximity Read ↗

Uptake of risk-reducing surgery in BRCA gene carriers in Wales, UK.Semantic proximity Read ↗

Germline testing for breast cancer patients in England: illogical to prioritise grade 1 breast cancer aged 30-39 over grade 3 aged 40-49 years?Semantic proximity Read ↗

Mainstreaming germline BRCA1/2 testing in non-mucinous epithelial ovarian cancer in the North West of EnglandSemantic proximity Read ↗

Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

The role of testing for BRCA1 and BRCA2 mutations in cancer prevention.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.